OPTINOSE INC. - COMMO
0.7616
20-9月-24 14:59:56
15 分の遅延
株式
-0.0340
-4.27%
本日の幅
0.7450 - 0.7900
ISIN
N/A
ソース
NASDAQ
-
Optinose Announces Pricing of Public Offering of Common Stock
16 11 2021 07:01:59 提供 Nasdaq GlobeNewswire
-
Optinose Announces Proposed Public Offering of Common Stock
15 11 2021 16:40:53 提供 Nasdaq GlobeNewswire
-
Optinose Reports Third Quarter 2021 Financial Results and Recent Operational Highlights
15 11 2021 15:26:45 提供 Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Third Quarter 2021 Financial Results
10 11 2021 16:50:01 提供 Nasdaq GlobeNewswire
-
Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis
28 10 2021 05:59:00 提供 Nasdaq GlobeNewswire
-
Optinose to Present at the Cantor Virtual Global Healthcare Conference
22 9 2021 15:15:00 提供 Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25 8 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Optinose Reports Second Quarter 2021 Financial Results and Recent Operational Highlights
11 8 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis
30 7 2021 07:00:01 提供 Nasdaq GlobeNewswire
-
Optinose Announces Preliminary Second Quarter 2021 XHANCE Net Revenue of $18.4 Million
28 7 2021 07:00:02 提供 Nasdaq GlobeNewswire
-
24 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Optinose to Present at the Jefferies Virtual Healthcare Conference
01 6 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Optinose Reports First Quarter 2021 Financial Results and Operational Updates
05 5 2021 06:00:01 提供 Nasdaq GlobeNewswire
-
28 4 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Optinose to Present at the Needham Virtual Healthcare Conference
12 4 2021 15:15:00 提供 Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Fourth Quarter 2020 Financial Results
17 2 2021 16:23:03 提供 Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25 1 2021 15:30:00 提供 Nasdaq GlobeNewswire